1. 钟南山 中国 广州医科大学 中国工程院院士 Response of upper and lower airway inflammation to bronchial challenge with house dust mite in Chine..
2. 袁国勇 中国 香港大学 中国工程院院士 Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients
3. 廖万清 中国 海军军医大学 中国工程院院士 Epidemiology of Cryptococcus and cryptococcosis in China
4. Ralph S. Baric 美国 University of North Carolina 2021美国科学院院士 Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe..
5. Choi, Augustine M.K. 美国 Weill Cornell Medical College 2020美国医学院院士 Autophagy in lung disease pathogenesis and therapeutics
6. Ralph S. Baric 美国 University of North Carolina 2021美国科学院院士 Molecular pathology of emerging coronavirus infections
7. 钟南山 中国 广州医科大学 中国工程院院士 An Intratracheal Challenge Murine Model of Asthma: Can Bronchial Inflammation Affect the Nose?
8. 钟南山 中国 广州医科大学 中国工程院院士 Impact of short term forced oral breathing induced by nasal occlusion on respiratory function in mic..
9. Ralph S. Baric 美国 University of North Carolina 2021美国科学院院士 Attenuation and Restoration of Severe Acute Respiratory Syndrome Coronavirus Mutant Lacking 2 '-O- M..
10. Choi, Augustine M.K. 美国 Weill Cornell Medical College 2020美国医学院院士 Autophagy: A Crucial Moderator of Redox Balance, Inflammation, and Apoptosis in Lung Disease
11. Gordon S,Mitchell 美国 University of Florida Progressive tauopathy disrupts breathing stability and chemoreflexes during presumptive sleep in mic..
12. Chen, Yee-Chun 中国 国立台湾大学 Video-assisted thoracoscopic surgery for primary pulmonary cryptococcosis
13. Sharon C.-A,Chen 澳大利亚 University of Sydney Pulmonary Cryptococcosis
14. Baniahmad, Aria 德国 Jena University Hospital Molecular mechanisms of inhibitor of growth (ING) family members in health and malignancy
15. Soudeh,Ghafouri-Fard 伊朗 SHAHID BEHESHTI UNIVERSITY MEDICAL SCIENCES Molecular mechanisms of inhibitor of growth (ING) family members in health and malignancy
16. Mohammad,Taheri 伊朗 SHAHID BEHESHTI UNIVERSITY MEDICAL SCIENCES Molecular mechanisms of inhibitor of growth (ING) family members in health and malignancy
17. Manish A,Shah 美国 Cornell University Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in adva..
18. David,Cunningham 英国 The Royal Marsden Hospital - London Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in adva..
19. Van Cutsem, Eric 比利时 Katholieke Universiteit Leuven(KU Leuven) Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in adva..
20. Scott D,Patterson 美国 Amgen Incorporated Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in adva..